One significant and interesting factor in the treatment of cancer is that tumor cells can also modulate sphingolipid metabolism with ceramidase, SphK and ATX to favor their survival and maintenance while blocking the patient’s immune system29,30. Here, SPHK1 is linked to neoplasm.